| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 123.397 | 121.910 | 76.009 | 110.899 | 129.645 | 178.678 | 182.994 | 210.340 | 234.702 | 270.593 |
| Total Income - EUR | 123.399 | 121.912 | 76.010 | 110.906 | 129.646 | 178.680 | 182.995 | 215.583 | 238.798 | 270.977 |
| Total Expenses - EUR | 137.518 | 121.395 | 74.667 | 96.327 | 121.077 | 166.793 | 163.098 | 186.559 | 219.367 | 240.016 |
| Gross Profit/Loss - EUR | -14.119 | 516 | 1.343 | 14.578 | 8.570 | 11.886 | 19.897 | 29.024 | 19.430 | 30.961 |
| Net Profit/Loss - EUR | -14.119 | 434 | 658 | 13.405 | 7.170 | 10.364 | 18.515 | 27.474 | 17.827 | 24.075 |
| Employees | 4 | 4 | 4 | 3 | 2 | 3 | 4 | 5 | 4 | 5 |
Check the financial reports for the company - Farmacia Yassmine Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 32.189 | 27.290 | 26.077 | 45.801 | 53.857 | 64.395 | 95.402 | 110.418 | 114.375 | 172.352 |
| Inventories | 16.232 | 13.960 | -182 | -28.163 | -59.783 | -81.083 | -72.843 | -82.167 | -116.550 | 162.289 |
| Receivables | 11.303 | 7.936 | 25.368 | 73.374 | 99.272 | 135.679 | 158.780 | 186.931 | 222.185 | 0 |
| Cash | 4.654 | 5.394 | 891 | 590 | 14.369 | 9.800 | 9.465 | 5.654 | 8.740 | 10.063 |
| Shareholders Funds | -12.742 | -12.179 | -11.315 | 2.298 | 9.423 | 15.349 | 33.524 | 61.102 | 72.193 | 95.865 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 44.932 | 39.469 | 37.392 | 43.503 | 44.434 | 49.046 | 61.878 | 49.316 | 42.182 | 76.487 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmacia Yassmine Srl